Nat Genet 50(7):912919
Telogen effluvium, the type of hair loss associated with GLP-1 agonists, is triggered by metabolic stress during rapid weight loss rather than by the drug directly
Preclinical Research The foundational preclinical research emerged from observations during Melanotan II trials when pronounced sexual arousal effects were noted as unexpected adverse events
Research has found that some drugs in these groups may lower the risk of heart disease, such as heart failure, stroke and kidney disease
Wegovy has shown remarkable effectiveness in promoting weight loss, with participants in clinical trials experiencing an average weight reduction of around 15% of their initial body weight
Once formed, AGEs can damage cellular structures through a number of mechanisms, including the formation of cross-links between key molecules of the basement membrane of the extracellular matrix and interaction with receptors on cell surfaces, leading to this way to alteration of cellular function [36, 37]
